Collplant Biotechnologies Ltd Cash Flow-to-Debt Ratio
Collplant Biotechnologies Ltd cash flow-to-debt ratio. Collplant Biotechnologies Ltd (CLGN) has a Cash Flow-to-Debt Ratio of -0.60x as of September 2025, meaning its operating cash flow of $-2.88 Million could theoretically repay -1% of its total liabilities ($4.78 Million) in one year. Check CLGN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Collplant Biotechnologies Ltd (2012–2024)
Cash flow-to-debt ratio of Collplant Biotechnologies Ltd from 2012 to 2024. Historical debt coverage capacity for Collplant Biotechnologies Ltd across 13 annual periods. Check CLGN cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Collplant Biotechnologies Ltd Cash Flow-to-Debt Ratio by Year (2012–2024)
Collplant Biotechnologies Ltd cash flow-to-debt ratio by year from 2012 to 2024. Year-by-year debt coverage analysis for Collplant Biotechnologies Ltd. For the full cash flow conversion analysis, see Collplant Biotechnologies Ltd (CLGN) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.69x | $-14.09 Million | $5.25 Million | ▼ -462.7% |
| 2023 | -0.48x | $-2.76 Million | $5.79 Million | ▲ +80.9% |
| 2022 | -2.50x | $-13.70 Million | $5.49 Million | ▼ -709.2% |
| 2021 | 0.41x | $2.50 Million | $6.10 Million | ▲ +158.6% |
| 2020 | -0.70x | $-4.45 Million | $6.36 Million | ▲ +18.3% |
| 2019 | -0.86x | $-5.70 Million | $6.66 Million | ▼ -201.7% |
| 2018 | -0.28x | $-1.22 Million | $4.29 Million | ▲ +68.8% |
| 2017 | -0.91x | $-4.97 Million | $5.46 Million | ▲ +56.3% |
| 2016 | -2.08x | $-5.02 Million | $2.41 Million | ▲ +46.2% |
| 2015 | -3.87x | $-3.72 Million | $960.64K | ▲ +20.8% |
| 2014 | -4.89x | $-3.33 Million | $679.77K | ▼ -17.3% |
| 2013 | -4.17x | $-3.82 Million | $915.72K | ▲ +13.9% |
| 2012 | -4.84x | $-3.86 Million | $797.87K | — |